Quince Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold QNCX, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
9
Funds holding
$126620
Total value held
Buying
5 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $47989 | 473259 | +1270 | +0.27% |
| 2 | State Street Corp | $25148 | 248011 | +17400 | +7.55% |
| 3 | Wells Fargo & Company/Mn | $23417 | 6990 | — | Held |
| 4 | Citigroup Inc | $21668 | 6468 | — | NEW BUY |
| 5 | Northern Trust Corp | $6685 | 65931 | -40291 | -37.93% |
| 6 | Goldman Sachs Group Inc | $1629 | 16064 | -213631 | -93.01% |
| 7 | Morgan Stanley | $84 | 834 | -9789 | -92.15% |
| 8 | Barclays Plc | $0 | 4 | — | NEW BUY |
| 9 | Royal Bank Of Canada | $0 | 3291 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.